- Home
- HFFG vs CMPX Comparison
HFFG vs CMPX Comparison
Compare HFFG & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HFFG
- CMPX
- Stock Information
- Founded
- HFFG N/A
- CMPX 2014
- Country
- HFFG United States
- CMPX United States
- Employees
- HFFG N/A
- CMPX N/A
- Industry
- HFFG Food Distributors
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- HFFG Consumer Discretionary
- CMPX Health Care
- Exchange
- HFFG Nasdaq
- CMPX Nasdaq
- Market Cap
- HFFG 162.4M
- CMPX 217.4M
- IPO Year
- HFFG N/A
- CMPX N/A
- Fundamental
- Price
- HFFG $3.43
- CMPX $1.71
- Analyst Decision
- HFFG
- CMPX Strong Buy
- Analyst Count
- HFFG 0
- CMPX 3
- Target Price
- HFFG N/A
- CMPX $7.67
- AVG Volume (30 Days)
- HFFG 33.2K
- CMPX 381.5K
- Earning Date
- HFFG 11-07-2024
- CMPX 11-07-2024
- Dividend Yield
- HFFG N/A
- CMPX N/A
- EPS Growth
- HFFG N/A
- CMPX N/A
- EPS
- HFFG 0.07
- CMPX N/A
- Revenue
- HFFG $1,160,322,000.00
- CMPX $850,000.00
- Revenue This Year
- HFFG N/A
- CMPX N/A
- Revenue Next Year
- HFFG N/A
- CMPX $950.68
- P/E Ratio
- HFFG $45.37
- CMPX N/A
- Revenue Growth
- HFFG N/A
- CMPX N/A
- 52 Week Low
- HFFG $2.46
- CMPX $0.77
- 52 Week High
- HFFG $5.91
- CMPX $2.34
- Technical
- Relative Strength Index (RSI)
- HFFG 54.71
- CMPX 68.40
- Support Level
- HFFG $3.02
- CMPX $1.42
- Resistance Level
- HFFG $3.31
- CMPX $1.65
- Average True Range (ATR)
- HFFG 0.21
- CMPX 0.14
- MACD
- HFFG 0.00
- CMPX 0.02
- Stochastic Oscillator
- HFFG 75.93
- CMPX 77.43
About HFFG HF Foods Group Inc.
HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The Company's business consists of one operating segment; HF Group, which operates solely in the United States. The Company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.